美盛文化(002699.SZ):子公司與北京寺庫共設新庫子
格隆匯 1 月 20日丨美盛文化(002699.SZ)公佈,公司控股子公司北京盛媒科技有限公司(“盛媒科技”)近日與北京寺庫天下投資有限公司(“北京寺庫”)共同投資設立北京新庫子科技有限公司(“新庫子”),註冊資本100萬元。北京寺庫的母公司為北京寺庫商貿有限公司,其為國內知名奢侈品電商平台,在奢侈品供應鏈方面具備完整的生態。雙方未來將協同發展公司旗下產品直播銷售業務。
目前,新庫子公司已完成工商註冊登記,並取得了北京市朝陽區市場監督管理局下發的《營業執照》。
設立合資公司是出於公司戰略規劃及經營發展需要,有利發揮雙方各自優勢,實現合作共贏,有利於提高公司綜合競爭能力,促進公司長期可持續發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.